Pillstats
Rx only · Tablet · Oral

Ranitidine

Ranitidine Hydrochloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)9143
US makers4 labelers
Packages28
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

106
Rx · 2026 Q1
5.7K
Units dispensed
1
Quarters · since 2026 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Dr.Reddy's laboratories Limitedunknown10SUPPLYING
Granules India Limitedunknown8SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown8SUPPLYING
Rising Pharma Holdings, Inc.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 13, 2019
    RECALLRecall (Class II): RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API — Recalling firm: Granules India Limited — OR, NY, NJ

  • Nov 22, 2019
    RECALLRecall (Class II): Ranitidine Tablets, USP 150 mg, 1000-count bottles, NDC 53746-253-10.

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API — Recalling firm: Amneal Pharmaceuticals, Inc. — Product was distributed throughout the United States.

  • Nov 22, 2019
    RECALLRecall (Class II): Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.

    CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API — Recalling firm: Amneal Pharmaceuticals, Inc. — Product was distributed throughout the United States.

  • Oct 1, 2019
    RECALLRecall (Class II): Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)

    CGMP Deviations: Presence of NDMA impurity detected in product. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Product was distributed to major distributors throughout the United States who may have further distributed the product.